Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-1996 | 02-1996 | 11-1995 | 08-1995 | 05-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,431 | 31,986 | N/A | N/A | N/A |
| Depreciation Amortization | 1,374 | 4,346 | N/A | N/A | N/A |
| Other Working Capital | 1,603 | -6,471 | N/A | N/A | N/A |
| Other Operating Activity | 0 | -296 | 0 | 0 | 0 |
| Operating Cash Flow | $8,408 | $29,565 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,976 | -15,907 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -2,627 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,976 | $-18,534 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 364 | 863 | 0 | 0 | 0 |
| Financing Cash Flow | $364 | $863 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 61,047 | 49,153 | N/A | N/A | N/A |
| End Cash Position | 65,843 | 61,047 | N/A | N/A | N/A |
| Net Cash Flow | $4,796 | $11,894 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,408 | 29,565 | N/A | N/A | N/A |
| Free Cash Flow | 8,408 | 29,565 | 0 | 0 | 0 |